450 related articles for article (PubMed ID: 33383805)
1. Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson's Disease.
Vuuren MJV; Nell TA; Carr JA; Kell DB; Pretorius E
Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33383805
[TBL] [Abstract][Full Text] [Related]
2. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
Nielsen SD; Pearson NM; Seidler K
Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
[TBL] [Abstract][Full Text] [Related]
3. Implications of the Gut Microbiome in Parkinson's Disease.
Elfil M; Kamel S; Kandil M; Koo BB; Schaefer SM
Mov Disord; 2020 Jun; 35(6):921-933. PubMed ID: 32092186
[TBL] [Abstract][Full Text] [Related]
4. Is Gut Dysbiosis an Epicenter of Parkinson's Disease?
Rajput C; Sarkar A; Sachan N; Rawat N; Singh MP
Neurochem Res; 2021 Mar; 46(3):425-438. PubMed ID: 33400024
[TBL] [Abstract][Full Text] [Related]
5. Human gut microbiota and Parkinson's disease.
Pant A; Bisht KS; Aggarwal S; Maiti TK
Prog Mol Biol Transl Sci; 2022; 192(1):281-307. PubMed ID: 36280322
[TBL] [Abstract][Full Text] [Related]
6. Oral and intestinal dysbiosis in Parkinson's disease.
Berthouzoz E; Lazarevic V; Zekeridou A; Castro M; Debove I; Aybek S; Schrenzel J; Burkhard PR; Fleury V
Rev Neurol (Paris); 2023 Nov; 179(9):937-946. PubMed ID: 36934020
[TBL] [Abstract][Full Text] [Related]
7. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
8. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
9. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
[TBL] [Abstract][Full Text] [Related]
10. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
Dogra N; Mani RJ; Katare DP
Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiome Imbalance and Neuroinflammation: Impact of COVID-19 on Parkinson's Disease.
Follmer C
Mov Disord; 2020 Sep; 35(9):1495-1496. PubMed ID: 32822087
[No Abstract] [Full Text] [Related]
12. The gut microbiome in Parkinson's disease: A culprit or a bystander?
Keshavarzian A; Engen P; Bonvegna S; Cilia R
Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment.
Salim S; Ahmad F; Banu A; Mohammad F
J Adv Res; 2023 Aug; 50():83-105. PubMed ID: 36332796
[TBL] [Abstract][Full Text] [Related]
14. Gut brain axis: an insight into microbiota role in Parkinson's disease.
Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of human alpha-Synuclein leads to dysregulated microbiome/metabolites with ageing in a rat model of Parkinson disease.
Singh Y; Trautwein C; Romani J; Salker MS; Neckel PH; Fraccaroli I; Abeditashi M; Woerner N; Admard J; Dhariwal A; Dueholm MKD; Schäfer KH; Lang F; Otzen DE; Lashuel HA; Riess O; Casadei N
Mol Neurodegener; 2023 Jul; 18(1):44. PubMed ID: 37403161
[TBL] [Abstract][Full Text] [Related]
16. Dysbiosis in Parkinson's disease might be triggered by certain antibiotics.
Ternák G; Kuti D; Kovács KJ
Med Hypotheses; 2020 Apr; 137():109564. PubMed ID: 31954994
[TBL] [Abstract][Full Text] [Related]
17. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.
Kelly LP; Carvey PM; Keshavarzian A; Shannon KM; Shaikh M; Bakay RA; Kordower JH
Mov Disord; 2014 Jul; 29(8):999-1009. PubMed ID: 24898698
[TBL] [Abstract][Full Text] [Related]
18. Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element.
Olivares D; Huang X; Branden L; Greig NH; Rogers JT
Int J Mol Sci; 2009 Mar; 10(3):1226-60. PubMed ID: 19399246
[TBL] [Abstract][Full Text] [Related]
19. TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut.
Gorecki AM; Anyaegbu CC; Anderton RS
Transl Neurodegener; 2021 Nov; 10(1):47. PubMed ID: 34814947
[TBL] [Abstract][Full Text] [Related]
20. The Link between Gut Dysbiosis and Neuroinflammation in Parkinson's Disease.
Baizabal-Carvallo JF; Alonso-Juarez M
Neuroscience; 2020 Apr; 432():160-173. PubMed ID: 32112917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
